Meet Daniel Pointing at SOCRA 2025 — Explore Regulatory-First AI in Action

We’re excited to share that Weave will be joining the Society of Clinical Research Associates (SOCRA) at their 2025 Annual Conference — the go‑to event for clinical research professionals, offering expert-led sessions, interactive workshops, peer‑driven poster programs, and rich networking opportunities

Event Details
Representative: Daniel Pointing, Associate Director, Business Development, Weave
Exhibit Dates: Friday, September 26 – Sunday, September 28, 2025 ‍
Location: Hyatt Regency Chicago, Chicago, IL
Event Website: SOCRA Annual Conference — [https://www.socra.org/annual-conference/2025/2025-annual-conference-information/

Visit the Weave Booth

Swing by our booth to meet Daniel Pointing and discover how Weave’s platform—purpose-built for regulatory workflows—can transform your documentation process with speed, precision, and confidence.

What we’ll showcase:

• How AI-native design (not just repurposed) enables seamless production of safety narratives, clinical study reports, and more
• Real-world strategies for slashing turnaround times on high-volume regulatory deliverables
• A look at maintaining rigorous traceability, auditability, and expert oversight in AI-powered workflows

Whether you’re modernizing systems or scaling for global regulatory safety programs, come connect with Daniel to see how Weave supports your goals.

Join Weave at NACCT 2025 and Explore The Weave Platform

We’re pleased to share that Weave will be present at the North American Congress of Clinical Toxicology (NACCT) 2025, the premier clinical toxicology gathering bringing together experts across healthcare, academia, poison centers, and regulatory bodies. Join us in Chicago to discover how AI-driven automation is redefining regulatory documentation workflows.

Event Details
Representative: Taylor Zeigler, Account Executive, Weave
Exhibit Dates: Friday, September 19 – Sunday, September 21, 2025
Location: Swissôtel Chicago, Chicago, IL ‍
Event Website: clintox.org/nacct

Visit the Weave Booth
Drop by our exhibit space to meet Taylor Zeigler and discover The Weave Platform—an AI-native solution built to streamline the creation of complex regulatory documents, including safety narratives, clinical study reports, and more.

We’ll share insights on:

• How teams in clinical toxicology and safety-focused workflows can automate document drafting without sacrificing quality
• Methods to significantly reduce turnaround time for high-volume deliverables
• What achievable traceability, precision, and expert oversight look like in AI-assisted environments

Whether you’re scaling up for large regulatory safety programs or modernizing workflows, we look forward to connecting and exploring how Weave can support your goals.

Join Weave at DPHARM 2025 – See How AI is Changing the Way We Build Regulatory Documents

We’re excited to share that Weave will be taking the stage at the 2025 DPHARM conference—a premier event spotlighting innovation in clinical development and R&D. DPHARM brings together top minds across pharma, biotech, and technology to challenge the status quo and accelerate smarter drug development.

Talk Details
Title: AI-Assisted Regulatory Writing: Findings from a Top 20 Pharma Case Study
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: September 17, 2025
Time: 1:55 – 2:05 PM Eastern Time
Location: The Westin Copley Place, Boston, MA
Event Website: dpharmconference.com

Session Overview
This session unveils final, unpublished findings from a groundbreaking collaboration between Weave and a Top 20 global pharmaceutical company. The study compares traditional regulatory writing with AI-assisted drafting using real-world data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, known for their complexity and criticality.

Key Takeaways:

• A side-by-side comparison of human-only vs. AI-augmented drafting
• A structured framework to evaluate speed and quality
• Actionable insights for applying AI in regulatory workflows—without compromising scientific integrity

Attendees will walk away with a pragmatic, evidence-based perspective on how AI tools can support—not replace—human expertise in regulatory science.

Visit the Weave Booth #408
Stop by our exhibit table to connect with the Weave team, including CCO Lindsay Mateo and Daniel Pointing, ADBD.
You’ll get a live demo of The Weave Platform, our AI-native solution that’s helping top pharma teams streamline content development and lifecycle management for regulatory submissions.

Whether you’re curious about where AI fits into your regulatory ecosystem or ready to modernize outdated workflows, we’d love to hear from you.

Let’s weave together the future of regulatory writing—see you at DPHARM!

Join Weave at Pharmaceutical Compliance Congress West – Don’t Miss Lindsay Mateo’s Talk on AI in Regulatory Strategy

We’re excited to announce that Lindsay Mateo, Chief Commercial Officer at Weave, will be speaking at Pharmaceutical Compliance Congress West 2025—a premier event convening regulatory, legal, and compliance leaders across the pharmaceutical industry.

Talk Details

Title: AI-Assisted Regulatory Writing: Findings from a Top 20 Pharma Case Study
Speaker: Lindsay Mateo, Chief Commercial Officer, Weave
Date: Friday, September 5, 2025
Time: 8:15 AM
Location: Estancia La Jolla – La Jolla, CA
Event Website: informaconnect.com/pharmaceutical-compliance-congress-west

Session Overview

This session unveils final, unpublished findings from a groundbreaking collaboration between Weave and a Top 20 global pharmaceutical company. The study compares traditional regulatory writing with AI-assisted drafting using real-world data from previously submitted INDs—specifically Sections 2.6.2, 2.6.4, and 2.6.6, known for their complexity and criticality.

Attendees will walk away with a pragmatic, evidence-based perspective on how AI tools can support—not replace—human expertise in regulatory science.

Key Takeaways:

• A side-by-side comparison of human-only vs. AI-augmented drafting
• A structured framework to evaluate speed and quality
• Actionable insights for applying AI in regulatory workflows—without compromising scientific integrity